COSCIENS Biopharma Inc.
CSCI.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.50% | -14.28% | -8.67% | -32.16% | -16.07% |
| Total Receivables | 58.13% | -21.43% | -42.33% | 49.70% | -24.77% |
| Inventory | -15.91% | -25.70% | -3.40% | -25.82% | -8.77% |
| Prepaid Expenses | -60.31% | 117.21% | -27.87% | 34.25% | -16.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -58.30% | -54.56% | -13.24% | -23.60% | 18.46% |
| Total Current Assets | -18.32% | -16.88% | -16.17% | -18.92% | -15.12% |
|
|
|||||
| Total Current Assets | -18.32% | -16.88% | -16.17% | -18.92% | -15.12% |
| Net Property, Plant & Equipment | -5.73% | -0.87% | -9.44% | 2.48% | -2.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 61.60% | -5.30% | 0.00% | 3.13% | 4.07% |
| Total Assets | -12.09% | -10.18% | -13.42% | -11.51% | -11.20% |
|
|
|||||
| Total Accounts Payable | -20.27% | -27.67% | -32.90% | -46.25% | 18.65% |
| Total Accrued Expenses | -70.83% | 23.29% | -39.83% | -19.39% | -19.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -13.49% | 1.42% | 1.44% | -17.39% | -6.64% |
| Total Finance Division Other Current Liabilities | -88.34% | 170.24% | -20.96% | 12.36% | -5.80% |
| Total Other Current Liabilities | -88.34% | 170.24% | -20.96% | 12.36% | -5.80% |
| Total Current Liabilities | -53.36% | -9.29% | -28.59% | -20.98% | -2.26% |
|
|
|||||
| Total Current Liabilities | -53.36% | -9.29% | -28.59% | -20.98% | -2.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.02% | -1.28% | -4.39% | 3.85% | -3.24% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -6.19% | 0.02% | 7.26% | -5.40% |
| Total Liabilities | -79.98% | -6.34% | -8.22% | -2.55% | -4.16% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.01% | 0.10% | 0.43% | 0.08% |
| Retained Earnings | 52.45% | -7.66% | -10.57% | -17.55% | -21.02% |
| Treasury Stock & Other | 41.66% | 14.61% | -12.65% | -24.91% | -17.56% |
| Total Common Equity | 298.72% | -24.37% | -28.42% | -30.04% | -22.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 298.72% | -24.37% | -28.42% | -30.04% | -22.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 298.72% | -24.37% | -28.42% | -30.04% | -22.92% |
|
|
|||||